Canavan disease is an inherited condition that affects the breakdown and use (metabolism) of aspartic acid.
Spongy degeneration of the brain; Aspartoacylase deficiency
Canavan disease is inherited as an autosomal recessive trait. It is more common among Ashkenazi Jews than in the general population.
The lack of the enzyme, aspartoacylase, leads to a buildup of material called N-acetylaspartic acid in the brain. This causes the white matter of the brain to break down (deteriorate).
Symptoms usually begin in the first year of life. Parents tend to notice when a child is not reaching certain developmental milestones, including head control.
Symptoms include:
Tests:
Treatment aims to ease the symptoms of the disease. There is no specific treatment.
Additional information and resources are available from:
Canavan Foundation
www.canavanfoundation.org
877-4-CANAVAN
With Canavan disease, the central nervous system breaks down. Patients are likely to become disabled.
Death often occurs before 18 months of age. However, some patients live until they are teenagers or, rarely, young adults.
This is often a fatal disorder. It includes severe disabilities such as:
Call your health care provider if your child has any symptoms of Canavan disease.
|
|
Reviewer Info: Chad Haldeman- Englert, MD, Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.; ADAM Health Illustrated Encyclopedia, 05/15/2008 |